Leids Universitair Medisch Centrum (LUMC) — Clinical Trial Site

323 Registered trials

170 Currently recruiting

Organisation

Leids Universitair Medisch Centrum (LUMC)

Location

Leiden, Netherlands

Identifier

ORG-100014145

Address

P.O. Box 9600, 2300 RC, Netherlands

Departments

#1001: Hematology
#3701: Nephrology
#3751: Hematology
#52803: Dept. of infectious diseases and (acute) internal medicine
1301: Hematology
2602: Medical Microbiology
2617:Cardiology
284014-0401: Gynecology/Obstetrics
3002: Oncologie
3701: Nephrology
3713: Cardiology
4500 : Medical Oncology
5001:Pulmonology
5280004: Ophthalmology
52801: ophthalmology
Afd. Hematologie
Akademisch Ziekenhuis Leiden
Anesthesiology
Cardiologie
Cardiology
Clinical epidemiology
Clinical Oncology
Department of Clinical Oncology
Department of Hematology
Department of Medical Oncology
Department of Medical Oncology (Clinical Research Unit)
Department of Medicine
Department of Neurology
Department of Obstetrics
Department of Obstetrics and Gynaecology
Department of oncology
Department of Psychiatry
Department of Pulmonary Diseases
Department of Pulmonology
Department of Pulmunology
Department of Rheumatology
Department of Surgery
dept
Dept of Internal Medicine
Dept of Oncology
Endocrinology
gastroenterology
Gastroenterology & Hepatology
Gastroenterology and hepatology
Gynaecologic oncology
Gynaecologie
Gynaecologische Oncologie
Gynaecology
Gynecology and obstetrics
Hämataology
Hartlong Centrum
Head and Neck surgery and otorhinolaryngology
Heelkunde
Hematology
hematology / oncology
IC Neonatology
Infectious Diseases
Infectious Diseases (LU-CID)
Internal Medicine
Internal Medicine - Thrombosis and Hemostasis
Internal Medicine and Nephrology
Internal medicine, nephrology
Internal Oncology
interne geneeskunde
Interne geneeskunde en infectieziekten
Kidney disease
Kindergeneeskunde
Klinische oncologie
Leiden University Medical Center
Leiden University Medical Centre
Leids Universitair Medisch Centrum
Longziekten
LUCID
LUCID - INZI
LUMC
Medical
Medical Oncology
Medicine - section Thrombosis and Hemostasis
Medische Oncologie
N/A
NA
Nefrologie
Nephrology
Neurologie
Neurology
Neuromuscular Diseases / Pediatrics
Neuromuscular Unit
Neurosurgery
NL10008: Internal Medicine
Not applicable
Nuclear Medicine
Oncologie
oncology
Ophthalmology
Otorhinolaryngology and head and neck surgery
Parasitology and Infectious Diseases
Pediatric gastroenterology
Pneumology
Polikliniek Reumatologie
Psychiatry
Public Health and Primary Care
Pulmonary
Pulmonary diseases
Pulmonary Medicine
Pulmonology
Radiotherapy
Reproductive medicine and gynecology
Research Facility
Rheumatology
Surgery
Urology

Clinical trials at this site (323)

Search interface

A trial to learn how safe rilvegostomig (AZD2936) is, how it moves throughout the body over time, and how well it works in adults with advan… Ended

2023-508262-15-00 Advanced Non-small Cell Lung Cancer, Metastatic Non-sma 7 2021-09-09
Pembrolizumab Plus Lenvatinib in Combination with Belzutifan in Solid Tumors Ended

2023-503905-12-00 Liver cancer; Colon cancer; Pancreatic cancer; Bile Duc 4 2021-08-20
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic… Ended

2023-506752-24-00 Locally recurrent inoperable or metastatic HR+/HER2- br 5 2021-08-05
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
NADINA Ended

2024-513519-28-00 Stage III melanoma 5 2021-07-23
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Locally advanced rectal cancer 4 2021-07-21
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) Ended

2023-504805-35-00 Lymphoma of B-cell origin 9 2020-10-22
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients wit… Ended

2024-514933-39-00 Patients with Advanced Tumors and Tenosynovial Giant Ce 7 2020-05-26
Phase 1/2 Study of CLN-081 in Patients with Lung Cancer Ended

2024-516532-97-00 Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Inser 9 2020-03-26
A Phase 3 Trial Comparing Selpercatinib to Cabozantinib or Vandetanib in Patients with RET-Mutant Medullary Thyroid Cancer Ended

2023-506782-56-00 RET-Mutant Medullary Thyroid Cancer 5 2020-03-10
Phase III randomized clinical trial for stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or withou… Ended

2023-509049-11-00 FIGO stage III ovarian cancer who are eligible for prim 5 2020-01-01
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Treatment of severe congenital Brittle bone disease after or before and after birth. Ended

2023-504593-38-00 Osteogenesis Imperfecta (OI) type III and severe type I 9 2019-08-12
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
A Study of combination of Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) compared to VELCADE, Lenalidomide, and … Ended

2023-506125-10-00 Multiple Myeloma 5 2018-12-24
HOVON 151 DLBCL: A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diff… Ended

2022-501076-26-00 high risk diffuse large B-cell lymphoma 4 2018-08-28
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d… Ended

2022-501038-48-00 Diffuse Large B-Cell Lymphoma 4 2018-07-26
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09
STAR-TREC: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision fo… Ended

2024-516106-31-00 Early stage colorectal cancer 10 2017-06-16
Further 2 years of adjuvant imatinib may improve recurrence-free survival (RFS) of patients who are at a high risk of GIST recurrence despit… Ended

2024-512243-23-00 gastrointestinal stromal tumor 5 2014-11-07
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01